Epilepsy Lesion Brain tumor Low grade glioma Mesiotemporal sclerosis MTS
Conditions
Interventions
None listed
Sponsors
Dr J.C. Reijneveld, neurologist
Department of Neurology - ZH 2F.35
VU University Medical Center
PO Box 7057
1007 MB Amsterdam
The Netherlands
T +31 20 4442821
F +31 20 4442800
Email: JC.Reijneveld@vumc.nl
Prof dr C.J. Stam, neurologist/neurophysiologist
Department of Clinical Neurophysiology – PK -1Z.142
VU University Medical Centre
PO Box 7057
1007 MB Amsterdam
The Netherlands
T +31 20 4440677
Email: CJ.Stam@vumc.nl
Drs. H.E. Ronner, neurophysiologist
Department of Clinical
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for pharmacoresistant epilepsy patients are: 1. Adult ( 18 years); 2. Patients who undergo resective surgical treatment at the VUmc regarding the Dutch Collaborative Epilepsy Surgery Program; 3. Have given written informed consent. For brain tumour patients with epilepsy, inclusion criteria are: 1. Adult ( 18 years); 2. Patients who undergo resective surgical treatment of the tumour with epilepsy surgery techniques at the VUmc; 3. Are suffering from epilepsy which was not pre-existent to the lesion; 4. Have given written informed consent.
Exclusion criteria
Exclusion criteria: Exclusion criteria are: 1. Psychiatric disease or symptoms; 2. Insufficient mastery of the Dutch language; 3. Inability to communicate adequately.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameters are a ECoG and MEG-based measures, assessing functional connectivity (SL and PLI) and neuronal brain networks (cluster coefficient and path length), seizure frequency and epilepsy burden. | — |
Contacts
Public ContactE. Dellen, van
Postbus 7057
Outcome results
None listed